AGC Flat Glass North America,Alpharetta,Ga.,and Asahi Glass,Tokyo,have been assigned a patent(8,273,595)developed by Christopher R.Cording,Kingsport,Tenn.,Matthew Spencer,Gray,Tenn.,and Kunio Masumo,Zama,Japan,for a"silicon thin film ...
Lighting Science Group has been awarded 26 new U.S.patents by the United States Patent and Trademark Office for 2012. It also reports another 20 patent applications that are expected to be issued in the next few months. A total of 71 ...
Tags: Lighting Science Group, patents, R&D team, lighting systems
The US Patent and Trademark Office (USPTO) will issue Patent No. 8,340,916 to Sequenom for its application covering methods of detecting fetal aneuploidy. The patent, which will be issued on 25 December 2012, covers claims related to ...
Tags: Sequenom, US patent, fetal aneuploidy, USPTO
The US Patent and Trademark Office (USPTO) has granted a patent to Pearl Therapeutics' co-suspension formulation technology for inhaled combinations. The Patent No. 8,324,266 covers methods for treating pulmonary disease using Pearl's ...
The US Patent and Trademark Office (USPTO) has granted new patent No. #8241330 to Lanx's Aspen MIS Fusion system, designed to support posterolateral fusions and interbody fusions. The Aspen system features proprietary spiked fixation ...
Tags: USPTO, MIS Fusion system, posterolateral fusions, interbody fusions
The United States Patent and Trademark Office has issued a patent for Lorus Therapeutics' LOR-253, which covers composition of matter and methods of treating cancer. The patent was initially set to expire in May 2026 and latter was ...
Bioplastics manufacturer Cereplast has secured patent protection for high heat resistant polymer compositions having polylactic acid (PLA), from the United States Patent and Trademark Office (USPTO). The patent 8,222,320 issued by USPTO ...
Tags: Resistant Polymer, bioplastic resin, patent protection
The US Patent and Trademark Office (USPTO) has granted a new Patent No. 8,298,554 to Amarin's pharmaceutical composition of ultra pure omega-3 fatty acid product. The patent covers the claims related to application No.12/769,885 for the ...
Tags: ultra pure omega-3 fatty acid product, vascepa capsules, icosapent ethyl
The US Patent and Trademark Office (USPTO) has granted a US Patent NO 8,185,485 B2 to Lifeline Biotechnologies' device used for analyzing thermal data based on breast surface temperature for the detection for use in determining cancerous ...
Tags: USPTO, Lifeline Biotechnologies'device, analyzing, surface temperature
Global specialty chemicals company Eastman Chemical has been assigned a patent number 8,287,970 for ‘plastic baby bottles, other blow molded articles, and processes for their manufacture.’ The patent has been developed by ...
Tags: baby bottles, advanced materials, chemicals and fibers
The US Patent and Trademark Office (USPTO) has granted a patent for the use of Aeterna Zentaris' oral ghrelin agonist, AEZS-130 (EP1572) as a diagnostic test for adult growth hormone deficiency (AGHD). AEZS-130, which has been granted ...
Tags: AEZS-130, growth hormone deficiency, AGHD
Critical Outcome Technologies has received a patent for its advanced oncology drug candidate, from the US Patent and Trademark Office. The patent covers the synergistic effects of combination therapies containing COTI-2 and members of ...
Tags: oncology drug, COTI-2, anti cancer agents
Coronado Biosciences has received notice of allowance for US patent application covering CNDO-109, from the US Patent and Trademark Office (USPTO). The patent is entitled, Method for activating natural killer cells by tumor cell ...
Tags: CNDO-109, cancer cells, AML
Corgenix Medical has received additional patent covering its AspirinWorks technology from the US Patent and Trademark Office. The patent is issued for the AspirinWorks Test Kit, which measures thromboxane metabolites in urine to evaluate ...
Tags: AspirinWorks technology, AspirinWorks test kit, Corgenix Medical
The US Patent and Trademark Office (USPTO) has granted notice of allowance (NOA) to SkyePharma for a patent application 2012/0177734 of RAYOS (Prednisone) delayed-release tablets. The NOA covers the FDA-approved RAYOS, which uses the ...
Tags: SkyePharma, RAYOS delayed-release tablets, rheumatoid arthritis